SUBSCRIBE
SUBSCRIBE

MAIA Biotechnology

IN THE PRESS
Press Releases
MAIA Biotechnology Presents Trial in Progress Poster at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 28, 2025
 · 
7 min read
Press Releases
MAIA Biotechnology Details 30-Month Patient Survival in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer
October 24, 2025
 · 
6 min read
Press Releases
MAIA Biotechnology Announces $736,600 Private Placement
October 14, 2025
 · 
4 min read
Press Releases
MAIA Biotechnology Announces $2.25 Million Private Placement
September 29, 2025
 · 
4 min read
Press Releases
MAIA Biotechnology Awarded $2.3 Million Grant by National Institutes of Health for THIO-101 Phase 2 Trial of Cancer-Fighting Agent
September 25, 2025
 · 
7 min read
Press Releases
MAIA Biotechnology Highlights Positive Efficacy Data from THIO-101 Phase 2 Clinical Trial in Non-Small Cell Lung Cancer
September 12, 2025
 · 
6 min read
Press Releases
MAIA Biotechnology Abstract Selected for Poster Presentation at 2025 IASLC World Conference on Lung Cancer
September 8, 2025
 · 
7 min read
Press Releases
MAIA Biotechnology Announces Publication of Interim Clinical Data on Telomere Targeting Anticancer Agent in Peer-Reviewed Journal Cells
August 28, 2025
 · 
5 min read
Press Releases
MAIA Biotechnology Granted European Patent for Next Generation Telomere-Targeting Agents for Cancer Therapy
August 14, 2025
 · 
5 min read
Press Releases
MAIA Biotechnology Receives FDA’s Fast Track Designation for Ateganosine as a Treatment for Non-Small Cell Lung Cancer
July 28, 2025
 · 
7 min read
Load More
JOBS